Science & Technology
A non-viral nanoparticle gene therapy delivery platform for treating Cystic Fibrosis and other diseases
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R43HL174181-01
Award Ceiling
$320K
Award Floor
$320K
Close Date
Jun 30, 2025
Total Funding
$320K
Expected Awards
1
Posted Date
Jul 1, 2024
Cost Sharing Required
No
Grants.gov ID
sbir-1R43HL174181-01
Description
SBIR Phase Phase I award: "A non-viral nanoparticle gene therapy delivery platform for treating Cystic Fibrosis and other diseases" awarded to OGB5, INC. in CINCINNATI, Ohio. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $320,251. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses, HUBZone businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.